Enhanced Serum Levels of sFlt1: Impact on Materno-Fetal CMV Transmission

Penka, Lukas; Kagan, Karl-Oliver; Hamprecht, Klaus

dc.contributor.author	Penka, Lukas
dc.contributor.author	Hamprecht, Klaus
dc.contributor.author	Kagan, Karl Oliver
dc.date.accessioned	2020-09-08T12:13:31Z
dc.date.available	2020-09-08T12:13:31Z
dc.date.issued	2020
dc.identifier.issn	2077-0383
dc.identifier.uri	http://hdl.handle.net/10900/106427
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/jcm9051258	de_DE
dc.subject.ddc	610	de_DE
dc.title	Enhanced Serum Levels of sFlt1: Impact on Materno-Fetal CMV Transmission	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_00568
utue.personen.roh	Penka, Lukas
utue.personen.roh	Kagan, Karl-Oliver
utue.personen.roh	Hamprecht, Klaus
dcterms.isPartOf.ZSTitelID	Journal of Clinical Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 1258	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE